Luyan Pharma Co

Luyan Pharma Co EBIT per Share

The EBIT per Share of Luyan Pharma Co (002788.SZ) as of Oct 23, 2026 is 1.56 CNY. In the previous year, EBIT per Share was 1.19 CNY — a change of 30.46% (higher).

EBIT per Share

1.56CNY

YoY

30.46%

Last updated:

EBIT per Share of Luyan Pharma Co is 2025 1.56 CNY. EBIT per Share of Luyan Pharma Co was 2024 1.19 CNY. It decreases by 30.46% higher compared to the previous year.

The Luyan Pharma Co EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
0.79 CNY
Jan 1, 2019
1.05 CNY
Jan 1, 2020
0.94 CNY
Jan 1, 2021
1.05 CNY
Jan 1, 2022
1.18 CNY
Jan 1, 2023
1.25 CNY
Jan 1, 2024
1.19 CNY
Jan 1, 2025
1.56 CNY
The Luyan Pharma Co EBIT per Share history
YEAREBIT per ShareYoY
1.56CNY+30.46%
1.19CNY-4.73%
1.25CNY+5.81%
1.18CNY+13.15%
1.05CNY+10.86%
0.94CNY-9.71%
1.05CNY+32.62%
0.79CNY+31.42%
0.60CNY+22.60%
0.49CNY-20.03%
0.61CNY+60.52%
0.38CNY+0.45%
0.38CNY-11.64%
0.43CNY+92.58%
0.22CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Luyan Pharma Co Stock analysis

What does Luyan Pharma Co do? Luyan Pharma Co Ltd, headquartered in Xiamen, Fujian, operates in the Health Care sector, specializing in the wholesale, distribution, manufacturing, and retail of pharmaceuticals, medical equipment, and healthcare products. The company, listed on 18 February 2016, serves medical institutions across Fujian Province, employing 5,286 full-time staff to support its operations in the region. Luyan Pharma Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Luyan Pharma Co stock

EBIT per Share of Luyan Pharma Co is 1.56 CNY in 2025.

EBIT per Share of Luyan Pharma Co changed from 1.19 CNY to 1.56 CNY, representing a 30.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Luyan Pharma Co since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Luyan Pharma Co

All Key Metrics — Luyan Pharma Co